High intensity exercise promotes escape of adrenocorticotropin and cortisol from suppression by dexamethasone: Sexually dimorphic responses

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 9, 1998, Pages 3332-3338

  Deuster, Patricia A ^a   Petrides, John S ^a   Singh, Anita ^a   Lucci, Edward B ^a   Chrousos, George P ^b   Gold, Philip W ^c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE;

ADULT; ARTICLE; CORTICOTROPIN RELEASE; EXERCISE; EXERCISE TEST; FEEDBACK SYSTEM; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROENDOCRINOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEX DIFFERENCE; STRESS;

ADRENOCORTICOTROPIC HORMONE; ADULT; ANXIETY; ARGININE VASOPRESSIN; BLOOD GLUCOSE; DEXAMETHASONE; EXERCISE; FEEDBACK; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; KINETICS; LACTIC ACID; MALE; OXYGEN CONSUMPTION; SEX CHARACTERISTICS;

EID: 0031741467     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.9.3332     Document Type: Article

References (37)

1. Chrousos GP, Gold PW. 1992 The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA. 267:1244-1252.
2. Crofford LJ, Pillemer SR, Kalogeras KT, et al. 1994 Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arth Rheum. 11:1583-1592.
3. Yehuda R, Giller EL, Southwick SM, Lowry MT, Mason JW. 1991 Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry. 30:1031-1048.
4. Stokes PE, Pick GR, Stoll PM, Nunn WD. 1975 Pituitary-adrenal function in depressed patients: resistance to dexamethasone suppression. J Psychiat Res. 12:271-281.
5. Von Bardeleben U, Holsboer F. 1989. Cortisol responses to a combined dexamethasone/human corticotropin-releasing hormone challenge test in patients with depression. J Neuroendocrinol. 1:485-488.
6. Heuser I, Yassouridis A, Holsboer F. 1994 The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiat Res. 28:341-356.
7. Schmider J, Lammers C-H, Gotthardt U, Dettling M, Holsboer F, Heuser IJE. 1995 Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls. Biol Psychiatry. 38:797-802.
8. Yanovski JA, Cutler GB, Chrousos GP, Nieman LK. 1993 Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA. 269:2232-2238.
9. Luger, A, Deuster PA, Kyle SB, et al. 1987 Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise: physiologic adaptations to physical training. N Engl J Med. 316:1309-1315.
10. Deuster PA, Chrousos GP, Luger A, et al. 1989 Hormonal and metabolic responses of untrained, moderately trained and highly trained men to three exercise intensities. Metabolism. 38:141-148.
11. Petrides JS, Mueller GP, Singh A, et al. 1997 Differential responses to exercise-induced activation of the Hypothalamic-pituitary-adrenal axis and arginine vasopressin stimulation. J Appl Physiol. 82:1979-1988.
12. Petrides JS, Mueller GP, Chrousos GP, Kalogeras K, Deuster PA. 1994 Exercise-induced activation of the hypothalamic-pituitary-adrenal (HPA) axis: differential sensitivity to glucocorticoid suppression. J Clin Endocrinol Metab. 79:377-383.
13. Kyle SB, Smoak BL, Douglass LW, Deuster PA. 1989 Variability of responses across training levels to maximal treadmill exercise. J Appl Physiol. 67:160-165.
14. Borg GAV. 1982 Psychological bases of perceived exertion. Med Sci Sports Exerc. 14:377-381.
15. Spielberger CS, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. 1983 Manual for the State-Trait Anxiety Inventory (form Y). Palo Alto: Consulting Psychologists Press.
16. Rittmaster RS, Cutler GB, Gold PW, et al. 1987 The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone stimulated ACTH and cortisol secretion in man. J Clin Endocrinol Metab. 64:371-376.
17. Malarkey WB, Lipkus IM, Cacioppo JT. 1995 The dissociation of catecholamine and hypothalamic-pituitary-adrenal responses to daily stressors using dexamethasone. J Clin Endocrinol Metab. 80:2458-2463.
18. Chrousos GP. 1995 The hypothalamic-pituitary adrenal axis and immune-mediated inflammation. N Engl J Med. 332:1351-1362.
19. Antoni FA. 1993 Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol. 14:76-122.
20. Debold CR, Sheldon WR, DeCherney GS, et al. 1984 Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J Clin Invest. 73:533-538.
21. Gillies GE, Linton EA, Lowry PJ. 1982 Corticotropin-releasing activity of the new CRH is potentiated several times by vasopressin. Nature. 299:355-357.
22. Salata RA, Jarret DB, Verbalis JG, Robinson AG. 1988 Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of coticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH. J Clin Invest. 81:766-774.
23. Bergland RM, Page RB. 1979 Pituitary-brain vascular relations: a new paradigm. Science. 204:18-24.
24. Alexander SL, Irvine CHG, Donald RA. 1996 Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis is determined using a nonsurgical method for collecting pituitary venous blood from horses. Front Neuroendocrinol. 17:1-50.
25. Holmes MC, Antoni FA, Aguilera G, Catt KJ. 1986 Magnocellular axons in passage through the median eminence release vasopressin. Nature. 319:326-329.
26. Baertschi AJ. 1980 Portal vascular route from hypophysial stalk/neural lobe to adenohypophysis. Am J Physiol 239:R463-R469.
27. Wotjak CT, Kubota M, Kohl G, Landgraf R. 1996 Release of vasopression from supraoptic neurons within the median eminence in vivo. A combined microdialysis and push-pull perfusion study in the rat. Brain Res. 726:237-241.
28. Whitnall MH. 1989 Stress selectively activates the vasopression-containing subsets of corticotropin-releasing hormone neurons. Neuroendocrinology. 50:702-707.
29. Whitnall MH, Perlstein RS, Mougey EH, Neta R. 1992 Effects of interleukin-1 on the stress-responsive and -nonresponsive subtypes of corticotropin-releasing hormone neurosecretory axons. Endocrinology. 131:37-44.
30. Chrousos GP. 1998 Editorial: ultradian, circadian, and stress-related hypothalamic-pituitary-adrenal axis activity a dynamic digital-to-analog modulation. Endocrinology. 139:437-440.
31. Maes M, Gastel AV, Meltzer HY, Cosyns P, Blockx P, Desnyder R. 1996 Acute administration of buspirone increases the escape of hypothalamic-adrenal-axis hormones from suppression by dexamethasone in depression. Psychoneuroendocrinology. 21:67-81.
32. Gold PW, Loriaux DL, Roy A, et al. 1986 Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease: pathophysiologic and diagnostic implications. N Engl J Med. 314:1329-1334.
33. Perraudin V, Delarue C, Lefebvre H, Contesse V, Kuhn JM, Vaudry H. 1993 Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors. J Clin Endocrinol Metab. 76:1522-1528.
34. Mazzochi G, Malendowicz LK, Meneghelli V, Gottardo G, Nussdorfer GG. 1995 In-vitro and in-vivo studies of the effects of arginine vasopressin on the secretion and growth of rat adrenal cortex. Histol Histopathol. 10:359-370.
35. Clauw DJ. 1995 The pathogenesis of chronic pain and fatigue syndromes, wilth special reference to fibromyalgia. Med Hypotheses. 44:369-378.
36. Deuster PA. 1996 Exercise in the prevention and treatment of chronic disorders. Women Health. 6:320-331.
37. Altemus M, Redwine L, Leong Y-M, et al. 1997 Reduced sensitivity to glucocorticoid feedback and reduced glucocorticoid receptor mRNA expression in the luteal phase of the menstrual cycle. Neuropsychopharmacology. 17: 100-109.